Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers

Emotions and brain function are altered up to one month after a single high dose of psilocybin

(2020) Frederick S. Barrett et al.   Scientific Reports

Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea Samples

(2020) Gabriela de Oliveira Silveira et al.   MOLECULES

The Role of BDNF on Neural Plasticity in Depression

(2020) Tao Yang et al.   Frontiers in Cellular Neuroscience

Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca

(2020) Nicole Leite Galvão-Coelho et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers

(2019) Anya K. Bershad et al.   BIOLOGICAL PSYCHIATRY

Associations between serum and plasma brain-derived neurotrophic factor and influence of storage time and centrifugation strategy

(2019) Anne Kær Gejl et al.   Scientific Reports

Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects

(2019) Friederike Holze et al.   NEUROPSYCHOPHARMACOLOGY

Systematic Balance Exercises Influence Cortical Activation and Serum BDNF Levels in Older Adults

(2019) Kubica et al.   Journal of Clinical Medicine

Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms

(2019) Rafael Guimarães dos Santos et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Modulation of Social Cognition via Hallucinogens and “Entactogens”

(2019) Katrin H. Preller et al.   Frontiers in Psychiatry

Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination

(2018) O. Grimm et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial

(2018) Fernanda Palhano-Fontes et al.   PSYCHOLOGICAL MEDICINE

BDNF levels are associated with autistic traits in the general population

(2018) Natascia Brondino et al.   PSYCHONEUROENDOCRINOLOGY

Psychedelics Promote Structural and Functional Neural Plasticity

(2018) Calvin Ly et al.   Cell Reports

Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls

(2018) Ana C. de Menezes Galvão et al.   Frontiers in Psychiatry

Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews

(2018) Rafael G. dos Santos et al.   Expert Review of Clinical Pharmacology

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression

(2017) Leor Roseman et al.   NEUROPHARMACOLOGY

Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression

(2017) J. B. Stroud et al.   PSYCHOPHARMACOLOGY

Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects

(2017) F Mueller et al.   Translational Psychiatry

Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression

(2016) Rafael Faria Sanches et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality

(2016) Patrick C Dolder et al.   NEUROPSYCHOPHARMACOLOGY

Effects of psychotropic drugs used in the treatment of anxiety disorders on the recognition of facial expressions of emotion: Critical analysis of literature

(2016) Alini Daniéli Viana Sabino et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

(2015) Flávia de L. Osório et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Emotion recognition from facial expressions: a normative study of the Ekman 60-Faces Test in the Italian population

(2014) Alessandra Dodich et al.   NEUROLOGICAL SCIENCES

Spatiotemporal Brain Dynamics of Emotional Face Processing Modulations Induced by the Serotonin 1A/2A Receptor Agonist Psilocybin

(2013) F. Bernasconi et al.   CEREBRAL CORTEX

Assessment of perception of morphed facial expressions using the Emotion Recognition Task: Normative data from healthy participants aged 8-75

(2013) Roy P.C. Kessels et al.   Journal of Neuropsychology

The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions

(2012) André Schmidt et al.   PSYCHOPHARMACOLOGY

Determination of dimethyltryptamine and β-carbolines (ayahuasca alkaloids) in plasma samples by LC–MS/MS

(2012) Carolina Dizioli Rodrigues Oliveira et al.   Bioanalysis

Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion

(2011) Draulio B. de Araujo et al.   HUMAN BRAIN MAPPING

Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca

(2011) Rafael G. dos Santos et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Pharmacology of ayahuasca administered in two repeated doses

(2011) Rafael G. dos Santos et al.   PSYCHOPHARMACOLOGY

Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus

(2010) Jucélia J. Fortunato et al.   JOURNAL OF NEURAL TRANSMISSION

Effects of β-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: Further evidence of antidepressant properties

(2009) Jucélia J. Fortunato et al.   BRAIN RESEARCH BULLETIN

Social anxiety disorder women easily recognize fearfull, sad and happy faces: The influence of gender

(2009) Kátia C. Arrais et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Human hallucinogen research: guidelines for safety

(2008) MW Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY